<DOC>
	<DOC>NCT01415505</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of nebivolol and valsartan given as a free tablet combination in patient with stage 1 or stage 2 essential hypertension.</brief_summary>
	<brief_title>Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Male or female outpatients of age 18 years or above Patients diagnosed with stage 1 or stage 2 essential hypertension Normal physical examination findings, electrocardiogram (ECG) results and chest xray; or abnormal findings judged by the Investigator to be not clinically significant Secondary hypertension or severe hypertension Clinically significant cardiovascular disease or heart failure A medical contraindication to discontinuing a current antihypertensive therapy History of Type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Stage 1</keyword>
	<keyword>Stage 2</keyword>
	<keyword>Hypertension</keyword>
	<keyword>1 year open label safety study</keyword>
</DOC>